Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP942354.RAn1oeGPqjKPbwKhnpxZxfaZtZ9OHpWK6LAOb-dXQs83I130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP942354.RAn1oeGPqjKPbwKhnpxZxfaZtZ9OHpWK6LAOb-dXQs83I130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP942354.RAn1oeGPqjKPbwKhnpxZxfaZtZ9OHpWK6LAOb-dXQs83I130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP942354.RAn1oeGPqjKPbwKhnpxZxfaZtZ9OHpWK6LAOb-dXQs83I130_provenance.
- befree-2016 importedOn "2016-02-19" NP942354.RAn1oeGPqjKPbwKhnpxZxfaZtZ9OHpWK6LAOb-dXQs83I130_provenance.
- NP942354.RAn1oeGPqjKPbwKhnpxZxfaZtZ9OHpWK6LAOb-dXQs83I130_assertion wasGeneratedBy ECO_0000203 NP942354.RAn1oeGPqjKPbwKhnpxZxfaZtZ9OHpWK6LAOb-dXQs83I130_provenance.
- NP942354.RAn1oeGPqjKPbwKhnpxZxfaZtZ9OHpWK6LAOb-dXQs83I130_assertion wasDerivedFrom befree-2016 NP942354.RAn1oeGPqjKPbwKhnpxZxfaZtZ9OHpWK6LAOb-dXQs83I130_provenance.
- NP942354.RAn1oeGPqjKPbwKhnpxZxfaZtZ9OHpWK6LAOb-dXQs83I130_assertion SIO_000772 22123319 NP942354.RAn1oeGPqjKPbwKhnpxZxfaZtZ9OHpWK6LAOb-dXQs83I130_provenance.
- NP942354.RAn1oeGPqjKPbwKhnpxZxfaZtZ9OHpWK6LAOb-dXQs83I130_assertion evidence source_evidence_literature NP942354.RAn1oeGPqjKPbwKhnpxZxfaZtZ9OHpWK6LAOb-dXQs83I130_provenance.
- NP942354.RAn1oeGPqjKPbwKhnpxZxfaZtZ9OHpWK6LAOb-dXQs83I130_assertion description "[Ipilimumab, a fully human monoclonal antibody that blocks cytotoxic T-lymphocyte antigen-4, has demonstrated an improvement in overall survival in two phase III trials of patients with advanced melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP942354.RAn1oeGPqjKPbwKhnpxZxfaZtZ9OHpWK6LAOb-dXQs83I130_provenance.